These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


164 related items for PubMed ID: 10337867

  • 41. Postprandial lipoprotein responses in hypertriglyceridemic subjects with and without cardiovascular disease.
    Hughes TA, Elam MB, Applegate WB, Bond MG, Hughes SM, Wang X, Tolley EA, Bittle JB, Stentz FB, Kang ES.
    Metabolism; 1995 Aug; 44(8):1082-98. PubMed ID: 7637651
    [Abstract] [Full Text] [Related]

  • 42. Dose-dependent action of atorvastatin in type IIB hyperlipidemia: preferential and progressive reduction of atherogenic apoB-containing lipoprotein subclasses (VLDL-2, IDL, small dense LDL) and stimulation of cellular cholesterol efflux.
    Guerin M, Egger P, Soudant C, Le Goff W, van Tol A, Dupuis R, Chapman MJ.
    Atherosclerosis; 2002 Aug; 163(2):287-96. PubMed ID: 12052475
    [Abstract] [Full Text] [Related]

  • 43. Comparison of gemfibrozil versus simvastatin in familial combined hyperlipidemia and effects on apolipoprotein-B-containing lipoproteins, low-density lipoprotein subfraction profile, and low-density lipoprotein oxidizability.
    Bredie SJ, de Bruin TW, Demacker PN, Kastelein JJ, Stalenhoef AF.
    Am J Cardiol; 1995 Feb 15; 75(5):348-53. PubMed ID: 7856526
    [Abstract] [Full Text] [Related]

  • 44. Integrated regulation of very low density lipoprotein triglyceride and apolipoprotein-B kinetics in non-insulin-dependent diabetes mellitus.
    Kissebah AH, Alfarsi S, Evans DJ, Adams PW.
    Diabetes; 1982 Mar 15; 31(3):217-25. PubMed ID: 7152129
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. The effect of a six-month exercise program on very low-density lipoprotein apolipoprotein B secretion in type 2 diabetes.
    Alam S, Stolinski M, Pentecost C, Boroujerdi MA, Jones RH, Sonksen PH, Umpleby AM.
    J Clin Endocrinol Metab; 2004 Feb 15; 89(2):688-94. PubMed ID: 14764782
    [Abstract] [Full Text] [Related]

  • 47. Relationship of low-density lipoprotein particle size to plasma lipoproteins, obesity, and insulin resistance in Japanese men.
    Suehiro T, Ohguro T, Sumiyoshi R, Yasuoka N, Nakauchi Y, Kumon Y, Hashimoto K.
    Diabetes Care; 1995 Mar 15; 18(3):333-8. PubMed ID: 7555476
    [Abstract] [Full Text] [Related]

  • 48. A randomized study comparing the effects of a low-carbohydrate diet and a conventional diet on lipoprotein subfractions and C-reactive protein levels in patients with severe obesity.
    Seshadri P, Iqbal N, Stern L, Williams M, Chicano KL, Daily DA, McGrory J, Gracely EJ, Rader DJ, Samaha FF.
    Am J Med; 2004 Sep 15; 117(6):398-405. PubMed ID: 15380496
    [Abstract] [Full Text] [Related]

  • 49. Whole egg consumption improves lipoprotein profiles and insulin sensitivity to a greater extent than yolk-free egg substitute in individuals with metabolic syndrome.
    Blesso CN, Andersen CJ, Barona J, Volek JS, Fernandez ML.
    Metabolism; 2013 Mar 15; 62(3):400-10. PubMed ID: 23021013
    [Abstract] [Full Text] [Related]

  • 50. Atorvastatin treatment beneficially alters the lipoprotein profile and increases low-density lipoprotein particle diameter in patients with combined dyslipidemia and impaired fasting glucose/type 2 diabetes.
    Pontrelli L, Parris W, Adeli K, Cheung RC.
    Metabolism; 2002 Mar 15; 51(3):334-42. PubMed ID: 11887170
    [Abstract] [Full Text] [Related]

  • 51. Effect of energy restriction, weight loss, and diet composition on plasma lipids and glucose in patients with type 2 diabetes.
    Heilbronn LK, Noakes M, Clifton PM.
    Diabetes Care; 1999 Jun 15; 22(6):889-95. PubMed ID: 10372237
    [Abstract] [Full Text] [Related]

  • 52. Endurance exercise training raises high-density lipoprotein cholesterol and lowers small low-density lipoprotein and very low-density lipoprotein independent of body fat phenotypes in older men and women.
    Halverstadt A, Phares DA, Wilund KR, Goldberg AP, Hagberg JM.
    Metabolism; 2007 Apr 15; 56(4):444-50. PubMed ID: 17378998
    [Abstract] [Full Text] [Related]

  • 53. Influence of etofibrate on LDL-subtype distribution in patients with diabetic dyslipoproteinemia.
    Geiss HC, Dietlein M, Parhofer KG.
    Exp Clin Endocrinol Diabetes; 2003 Sep 15; 111(6):322-4. PubMed ID: 14520596
    [Abstract] [Full Text] [Related]

  • 54. LDL subclass phenotypes and the insulin resistance syndrome in women.
    Selby JV, Austin MA, Newman B, Zhang D, Quesenberry CP, Mayer EJ, Krauss RM.
    Circulation; 1993 Aug 15; 88(2):381-7. PubMed ID: 8339401
    [Abstract] [Full Text] [Related]

  • 55. Intensive insulin therapy reduces small dense low-density lipoprotein particles in patients with type 2 diabetes mellitus: relationship to triglyceride-rich lipoprotein subspecies.
    Hayashi T, Hirano T, Yamamoto T, Ito Y, Adachi M.
    Metabolism; 2006 Jul 15; 55(7):879-84. PubMed ID: 16784958
    [Abstract] [Full Text] [Related]

  • 56. Insulin resistance is independently associated with postprandial alterations of triglyceride-rich lipoproteins in type 2 diabetes mellitus.
    Annuzzi G, De Natale C, Iovine C, Patti L, Di Marino L, Coppola S, Del Prato S, Riccardi G, Rivellese AA.
    Arterioscler Thromb Vasc Biol; 2004 Dec 15; 24(12):2397-402. PubMed ID: 15458975
    [Abstract] [Full Text] [Related]

  • 57. Influence of early diabetic nephropathy on very low density lipoprotein (VLDL), intermediate density lipoprotein (IDL), and low density lipoprotein (LDL) composition.
    Winocour PH, Durrington PN, Bhatnagar D, Ishola M, Mackness M, Arrol S.
    Atherosclerosis; 1991 Jul 15; 89(1):49-57. PubMed ID: 1772471
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. Differential regulation of lipoprotein kinetics by atorvastatin and fenofibrate in subjects with the metabolic syndrome.
    Watts GF, Barrett PH, Ji J, Serone AP, Chan DC, Croft KD, Loehrer F, Johnson AG.
    Diabetes; 2003 Mar 15; 52(3):803-11. PubMed ID: 12606523
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 9.